BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+26.47%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.37B
AUM Growth
+$2.37B
Cap. Flow
-$70.6M
Cap. Flow %
-2.98%
Top 10 Hldgs %
45.23%
Holding
88
New
8
Increased
6
Reduced
18
Closed
10

Top Buys

1
AXSM icon
Axsome Therapeutics
AXSM
$135M
2
ZYME icon
Zymeworks
ZYME
$46.1M
3
IMVT icon
Immunovant
IMVT
$45.5M
4
PNT
POINT Biopharma Global Inc. Common Stock
PNT
$26.2M
5
REPL icon
Replimune Group
REPL
$16.2M

Top Sells

1
RLMD icon
Relmada Therapeutics
RLMD
$76.9M
2
IONS icon
Ionis Pharmaceuticals
IONS
$66.1M
3
CINC
CinCor Pharma, Inc. Common Stock
CINC
$43.1M
4
NUVL icon
Nuvalent
NUVL
$32.4M
5
EQRX
EQRx, Inc. Common Stock
EQRX
$29.7M

Sector Composition

1 Healthcare 99.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRDN icon
26
Viridian Therapeutics
VRDN
$1.57B
$36.2M 1.53%
1,238,974
-502,866
-29% -$14.7M
ITOS
27
DELISTED
iTeos Therapeutics
ITOS
$35.4M 1.49%
1,810,835
– –
LXRX icon
28
Lexicon Pharmaceuticals
LXRX
$400M
$30.8M 1.3%
16,149,179
– –
CBIO
29
Crescent Biopharma, Inc. Common Stock
CBIO
$186M
$28.9M 1.22%
9,544,262
– –
RAIN
30
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$28.2M 1.19%
3,526,729
– –
STRO icon
31
Sutro Biopharma
STRO
$83.1M
$27.1M 1.14%
3,347,946
-100,000
-3% -$808K
SLN
32
Silence Therapeutics
SLN
$237M
$23M 0.97%
1,508,416
– –
VIGL
33
DELISTED
Vigil Neuroscience
VIGL
$22.7M 0.96%
1,813,633
– –
EPIX icon
34
ESSA Pharma
EPIX
$11.3M
$22M 0.93%
8,748,629
– –
CNTA
35
Centessa Pharmaceuticals
CNTA
$2.12B
$21.4M 0.9%
6,894,345
– –
CNCE
36
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$21.2M 0.89%
3,629,000
– –
ANNX icon
37
Annexon
ANNX
$226M
$19.5M 0.82%
3,780,694
– –
JANX icon
38
Janux Therapeutics
JANX
$1.38B
$19.4M 0.82%
1,470,334
– –
TYRA icon
39
Tyra Biosciences
TYRA
$660M
$18.8M 0.79%
2,472,327
– –
THRD
40
DELISTED
Third Harmonic Bio
THRD
$18.8M 0.79%
4,365,933
+864,119
+25% +$3.72M
OLMA icon
41
Olema Pharmaceuticals
OLMA
$427M
$18.6M 0.79%
7,611,503
– –
NAMS icon
42
NewAmsterdam Pharma
NAMS
$2.81B
$16M 0.68%
+1,521,948
New +$16M
ACIU icon
43
AC Immune
ACIU
$226M
$15.2M 0.64%
7,428,379
– –
ANTX icon
44
AN2 Therapeutics
ANTX
$34.4M
$14.9M 0.63%
1,563,963
-52,702
-3% -$502K
CALT
45
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$13.1M 0.55%
750,000
– –
OVID icon
46
Ovid Therapeutics
OVID
$92.4M
$12.7M 0.54%
6,851,051
– –
VERV
47
DELISTED
Verve Therapeutics
VERV
$12.6M 0.53%
650,000
– –
COGT icon
48
Cogent Biosciences
COGT
$1.81B
$11.4M 0.48%
984,824
-1,100,000
-53% -$12.7M
CTMX icon
49
CytomX Therapeutics
CTMX
$343M
$10.6M 0.45%
6,595,801
– –
ALPN
50
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$8.35M 0.35%
1,135,940
– –
1
2
3 4